Oxidative stress in ageing of hair

Ralph M Trüeb, Ralph M Trüeb

Abstract

Experimental evidence supports the hypothesis that oxidative stress plays a major role in the ageing process. Reactive oxygen species are generated by a multitude of endogenous and environmental challenges. Reactive oxygen species or free radicals are highly reactive molecules that can directly damage cellular structural membranes, lipids, proteins, and DNA. The body possesses endogenous defence mechanisms, such as antioxidative enzymes and non-enzymatic antioxidative molecules, protecting it from free radicals by reducing and neutralizing them. With age, the production of free radicals increases, while the endogenous defence mechanisms decrease. This imbalance leads to the progressive damage of cellular structures, presumably resulting in the ageing phenotype. Ageing of hair manifests as decrease of melanocyte function or graying, and decrease in hair production or alopecia. There is circumstantial evidence that oxidative stress may be a pivotal mechanism contributing to hair graying and hair loss. New insights into the role and prevention of oxidative stress could open new strategies for intervention and reversal of the hair graying process and age-dependent alopecia.

Keywords: Androgenetic alopecia; graying; oral antioxidative supplementation therapy; oxidative stress; senescent alopecia; topical melatonin.

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Tobin DJ, Paus R. Graying: Gerontobiology of the hair follicle pigmentary unit. Exp Gerontol. 2001;36:29–54.
    1. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300.
    1. Shindo Y, Witt E, Han D, Epstein W, Packer L. Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin. J Invest Dermatol. 1994;102:122–4.
    1. Commo S, Gaillard O, Bernard BA. Human hair greying is linked to a specific depletion of hair follicle melanocytes affecting both the bulb and the outer root sheath. Br J Dermatol. 2004;150:435–43.
    1. Arck PC, Overall R, Spatz K, Liezman C, Handjiski B, Klapp BF, et al. Towards a 'free radical theory of graying': Melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage. FASEB J. 2006;20:1567–9.
    1. Wood JM, Decker H, Hartmann H, Chavan B, Rokos H, Spencer JD, et al. Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J. 2009 Feb 23. [Epub ahead of print]
    1. Spencer JD, Gibbons NC, Rokos H, Peters EM, Wood JM, Schallreuter KU. Oxidative stress via hydrogen peroxide affects propriomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol. 2007;127:411–20.
    1. Spencer JD, Gibbons NC, Böhm M, Schallreuter KU. The Ca2+-binding capacity of epidermal furin is disrupted by H2O2-mediated oxidation in vitiligo. Endocrinology. 2008;149:163–45.
    1. Schallreuter KU, Wood JM, Pittelkow MR, Gütlich M, Lemke KR, Rödl W, et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science. 1994;263:1444–6.
    1. Nishimura EK, Jordan SA, Oshima H, Yoshida H, Osawa M, Moriyama M, et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature. 2002;416:854–60.
    1. Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: Incomplete melanocyte stem cell maintenance in the niche. Science. 2005;307:720–4.
    1. Hollfelder B, Blankenburg G, Wolfram LJ, Höcker H. Chemical and physical properties of pigmented and non-pigmented hair ('grey hair') Int J Cosmet Sci. 1995;17:87–9.
    1. Nagl W. Different growth rates of pigmented and white hair in the beard: Differentiation vs. proliferation? Br J Dermatol. 1995;132:94–7.
    1. van Neste D. Thickness, medullation and growth rate of female scalp hair are subject to significant variation according to pigmentation of scalp location during aging. Eur J Dermatol. 2004;14:28–32.
    1. van Neste D, Tobin DJ. Hair cycle and hair pigmentation: Dynamic interactions and changes associated with aging. Micron. 2004;35:193–200.
    1. Norwood OT. Male pattern baldness: Classification and incidence. South Med J. 1975;68:1359–65.
    1. Norwood OT. Incidence of female androgenetic alopecia (female pattern alopecia) Dermatol Surg. 2001;27:53–4.
    1. Trüeb RM. Molecular mechanisms in androgenetic alopecia. Exp Gerontol. 2002;37:981–90.
    1. Kaufman KD. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermtol Clin. 1996;14:697–711.
    1. Randall VA, Thornton MH, Messenger AG. Cultured dermal papilla cells from androgen-dependent human hair follicles (e.g beard) contain more androgen receptors than those from non-balding ares of the scalp. J Endocrinol. 1992;133:141–7.
    1. Itami S, Kurata S, Takayasu S. Androgen induction of follicular epithelial cell growth mediated via insulin-like growth factor I from dermal papilla cells. Biochem Biopshys Res Commun. 1995;221:988–94.
    1. Hibberts NA, Messenger AG, Randall VA. Dermal papilla cells derived from beard hair follicles secrete more stem cell factor (SCF) in culture than scalp cells or dermal fibroblasts. Biochem Biophys Res Commun. 1996;222:401–5.
    1. Naito A, Midorikawa T, Yoshino T, Ohdera M. Lipid peroxides induce early onset of catagen phase in murine hair cycles. Int J Mol Med. 2008;22:725–9.
    1. Bahta AW, Farjo N, Farjo B, Philpott MP. Premature senescence of balding dermal papilla cells in vitro is associated with p16(INK4a) expression. J Invest Dermatol. 2008;128:1088–94.
    1. Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: Implications for pathogenesis. Br J Dermatol. 1992;127:239–46.
    1. Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol. 1993;28:755–63.
    1. Mahé YF, Michelet JF, Billoni N, Jarrousse F, Buan B, Commo S, et al. Androgenetic alopecia and microinflammation. Int J Dermatol. 2000;39:576–84.
    1. Kossard S. Postmenopausal frontal fibrosing alopecia. Arch Dermatol. 1994;130:770–4.
    1. Zinkernagel MS, Trüeb RM. Fibrosing alopecia in a pattern distribution. Patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern? Arch Dermatol. 2000;136:205–11.
    1. Eichmüller S, van der Veen C, Moll I, Hermes B, Hofmann U, Müller-Röver S, et al. Clusters of perifollicular macrophages in normal murine skin: Physiological degeneration of selected hair follicles by programmed organ deletion. J Histochem Cytochem. 1998;46:361–70.
    1. Philpott MP, Sander DA, Bowen J, Kealey T. Effects of interleukins, colony stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: A possible role for interleukin-1 and tmour necrosis factor-α in alopecia areata. Br J Dermatol. 1996;135:942–8.
    1. Kligman AM. The comparative histopathology of male-pattern baldness and senescent baldness. Clin Dermatol. 1998;6:108–18.
    1. Paradi M, Karnik P. Comparative gene expression profiling of senescent and androgenetic alopecia using microarray analysis. In: Trüeb RM, Tobin D, editors. Aging Hair. Springer (in preparation)
    1. Courtois M, Loussouarn G, Hourseau C, Grollier JF. Aging and hair cycles. Br J Dermatol. 1995;132:86–93.
    1. Sinclair R, Chapman A, Magee J. The lack of significant changes in scalp hair follicle density with advancing age. Br J Dermatol. 1005;152:646–9.
    1. Yaar M, Gilchrest BA. Ageing of skin. In: Friedberg IM, Eisen AZ, Wolff K, et al., editors. Fizpatrick's Dermatology in General Practice. 5th ed. New York: McGraw Hill; 1999. pp. 1697–706.
    1. Mosley JG, Gibbs CC. Premature grey hair and hair loss among smokers: A new opportunity for health education? BMJ. 1996;313:1616.
    1. Su LH, Chen TH. Association of androgenetic alopecia with smoking and its prevalence among Asian men: A community-based survey. Arch Dermatol. 2007;143:1401–6.
    1. Trüeb RM. Association between smoking and hair loss: Another opportunity for health education against smoking? Dermatology. 2003;206:189–91.
    1. Black HS. Potential involvement of free radical reactions in ultraviolet light-mediated cutaneous damage. Photochem Photobiol. 1987;46:213–21.
    1. Santos Nogueira AC, Joekes I. Hair color changes and protein damage caused by ultraviolet radiation. J Photochem Photobiol B. 2004;74:109–17.
    1. Nogueira AC, Dicelio LE, Joekes I. About photo-damage of human hair. Photochem Photobiol Sci. 2006;5:165–9.
    1. Jeon SY, Pi LQ, Lee WS. Comparison of hair shaft damage after UVA and UVB irradiation. J Cosmet Sci. 2008;59:151–6.
    1. Trüeb RM. Is androgenetic alopecia a photoaggravated dermatosis? Dermatology. 2003;207:343–8.
    1. Camacho F, Moreno JC, Garcia-Hernández Telogen alopecia from UV rays. Arch Dermatol. 1996;132:1398–9.
    1. Johnsson A, Kjeldstad B, Melo TB. Fluorescence from pilosebaceous follicles. Arch Dermatol Res. 1987;279:190–3.
    1. Piérard-Franchimont C, Uhoda I, Saint-Léger D, Piérard GE. Androgenetic alopecia and stress-induced premature senescence by cumulative ultraviolet light exposure. Exog Dermatol. 2002;1:203–6.
    1. Pande CM, Albrecht L, Yang B. Hair photoprotection by dyes. J Cosmet Sci. 2001;52:377–89.
    1. Gao T, Bedell A. Ultraviolet damage on natural gray hair and ist photoprotection. J Cosmet Sci. 2001;52:103–18.
    1. Wissing SA, Muller RH. Solid lipid nanoparticles (SLN) – a novel carrier for UV blockers. Pharmazie. 2001;56:783–6.
    1. Fuchs J, Huflejt ME, Rothfuss LM, Wilson DS, Carcamo G, Packer L. Impairment of enzymic and nonenzymic antioxidants in skin by UVB irradiation. J Invest Dermatol. 1989;93:769–73.
    1. Eberlein-König B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E) J Am Acad Dermatol. 1998;38:45–8.
    1. Mireles-Rocha H, Galindo I, Huerta M, Trujillo-Hernández B, Elizalde A, Cortés-Franco R. UVB photoprotection with antioxidants: Effects of oral therapy with d-alpha-tocopherol and ascorbic acid on the minimal erythema dose. Acta Derm Venereol. 2002;82:21–4.
    1. Greul AK, Grundmann JU, Heinrich F, Pfitzner I, Bernhardt J, Ambach A, et al. Photoprotection of UV-irradiated human skin: An antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl Skin Physiol. 2002;15:307–15.
    1. Lin FH, Lin JY, Gupta RD, Tournas JA, Burch JA, Selim MA, et al. Ferulic acid stabilizes a solution of vitamins A and E and doubles its photoprotection of skin. J Invest Dermatol. 2005;125:826–32.
    1. Cho HS, Lee MH, Lee JW, No KO, Park SK, Lee HS, et al. Anti-wrinkling effects of the mixture of vitamin C, vitamin E, pycnogenol and evening primrose oil, and molecular mechanisms on hairless mouse skin caused by chronic ultraviolet B irradiation. Photodermatol Photoimmunol Photomed. 2007;23:155–62.
    1. D'Agostini F, Balansky R, Pesce C, Fiallo P, Lubet RA, Kelloff GJ, et al. Induction of alopecia in mice exposed to cigarette smoke. Toxicol Lett. 2000;3(114):117–23.
    1. D'Agostini F, Fiallo P, Pennisi TM, De Flora S. Chemoprevention of smoke- induced alopecia in mice by oral administration of L-cystine and vitamin B6. J Dermatol Sci. 2007;46:189–98.
    1. Lengg N, Heidecker B, Seifert B, Trüeb RM. Dietary supplement increases anagen hair rate in women with telogen effluvium: Results of a double-blind placebo-controlled trial. Therapy. 2007;4:59–65.
    1. Reiter RJ, Poeggeler B, Tan DX. Antioxidant capacity of melatonin: A novel action not requiring a receptor. Neuroendocrinol Lett. 1993;15:103–16.
    1. Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM, et al. Melatonin: A hormone, a tissue factor, an auotocoid, a paracoid, and an antioxidant vitamin. J Pineal Res. 2003;34:75–8.
    1. Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, et al. Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem. 2002;2:181–97.
    1. Pierpaoli WE, Maereoni GM. Melatonin: A principal neuroimmunoregulatory and ant-stress hormone: Its anti-aging effects. Immunol Lett. 1987;16:355–62.
    1. Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez A, Chen LD, Saarela S. Melatonin as a free radical scavanger: Implications for aging and age-related diseases. Ann N Y Acad Sci. 1994;719:1–12.
    1. Slominski A, Pisarchik A, Semak I, Sweatman T, Wortsman J, Szczesniewski A, et al. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J. 2002;16:896–98.
    1. Slominski A, Pisarchik A, Zbytek B, Tobin DJ, Kauser S, Wortsman J. Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol. 2003;196:144–53.
    1. Hipler UC, Fischer TW, Elsner P. HaCaT cell proliferation influenced by melatonin. Skin Pharmacol Appl Skin Physiol. 2003;16:379–85.
    1. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine) Arch Dermatol Res. 1996;288:522–6.
    1. Dreher F, Gabard B, Schwindt DA, Maibach HI. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: A human study in vivo. Br J Dermatol. 1998;139:332–9.
    1. Fischer TW, Scholz G, Knoll B, Hipler UC, Elsner P. Melatonin reduces UV-induced reactive oxygen species in a dose-dependent manner in IL-3-stimulated leukocytes. J Pineal Res. 2001;31:39–45.
    1. Fischer TW, Scholz G, Knoll B, Hipler UC, Elsner P. Melatonin suppresses reactive oxygen species in UV-irradiated leukocytes more than vitamin C and trolox. Skin Pharmacol Appl Skin Physiol. 2002;15:367–73.
    1. Fischer TW, Scholz G, Knoll B, Hipler UC, Elsner P. Melatonin suppresses reactive oxygen species induced by UV irradiation in leukocytes. J Pineal Res. 2004;37:107–12.
    1. Fischer TW, Burmeister G, Schmidt HW, Elsner P. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: Results of a pilot randomized controlled trial. Br J Dermatol. 2004;150:341–5.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi